Analytical study on maternal and fetal outcome of pre-eclampsia with severe features at tertiary care hospital
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20241443Keywords:
PE with severe feature, Pritchard regimen, Primigravida, Mgso4Abstract
Background: Pre-eclampsia is a multi-system, pregnancy specific disorder that is characterized by the development of hypertension and proteinuria after 20 weeks. Pre-eclampsia is the majority of referrals to tertiary care centre. It is one of the major causes of maternal and perinatal morbidity and mortality.
Methods: A retrospective analytical study done over a period of six months from January 1st 2023 to June 30th 2023. Pregnant women admitted with PE with severe features to Cheluvamba hospital, MMCRI, Mysore during the study were considered and analysed using the proforma. Data was entered into Microsoft excel data sheet and was analyzed. Categorical data was represented in the form of Frequencies and proportions
Results: Incidence of PE with severe features in our hospital was 3.4%. Majority (69%) were between 23-27 years of age and 52.7% were primigravida. Maternal complications were noted in 37.5% attributed to renal dysfunction, postpartum haemorrhage, DIC, placental abruption, HELLP, pulmonary oedema and postpartum eclampsia.
Conclusions: Maternal and perinatal complications are more in patients with severe pre-eclampsia. The incidence of severe pre-eclampsia can be reduced by early referral, better antenatal care, early recognition and treatment of pre-eclampsia
Metrics
References
Ying W, Catov JM, Ouyang P. Hypertensive disorders of pregnancy and future maternal cardiovascular risk. J Am Heart Assoc. 2018;7(17):e009382.
Mou AD, Barman Z, Hasan M, Miah R, Hafsa JM, Das Trisha A, et al. Prevalence of pre-eclampsia and the associated risk factors among pregnant women in Bangladesh. Sci Rep. 2021;11(1):21339.
Brown MA, Magee LA, Kenny LC, Karumanchi SA, McCarthy FP, Saito S, et al. The hypertensive disorders of pregnancy: ISSHP classification, diagnosis and management recommendations for international practice. Pregnancy Hypertens. 2018;13:291-310.
Chaemsaithong P, Sahota DS, Poon LC. First trimester pre-eclampsia screening and prediction. Am J Obstet Gynecol. 2022;226:(2S):1071-97.
Tranquilli AL, Dekker G, Magee L, Roberts J, Sibai BM, Steyn W, et al. The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP. Pregnancy Hypertens. 2014;4(2):97-104.
Cunningham F, Leveno KJ, Dashe JS, Hoffman BL, Spong CY, Casey BM (Eds.), Williams Obstetrics, 26e. McGraw Hill. 2022.
Queensland Clinical Guidelines. Hypertension and Pregnancy. 2021. Available at: http://www.health.qld.gov.au/qcg. Accessed on 8 March, 2024.
Office of the Registrar General and Census Commissioner: India, Ministry of Home affairs, Government of India, in the SRS Bulletins. Available at: https://censusindia.gov.in/nada/index.php/catalog/34781. Accessed on 8 March, 2024.
Maternal health. Available at: https://www.unicef.org/india/what-we-do/maternal-health. Accessed on 8 March, 2024
Meh C, Sharma A, Ram U, Fadel S, Correa N, Snelgrove JW, et al. Trends in maternal mortality in India over two decades in nationally representative surveys. BJOG. 2022;129:550-61.
Mallick S, Barik N, Pradhan S. Gestational hypertension and fetal outcome: A prospective study in a tertiary care centre. Indian J Obstet Gynecol Res. 2020;7(4):595-9.
Hemapriya L, Bhandiwad A, Desai N. Maternal complications of hypertension in pregnancy-A five year study. Ind J Obstet Gynecol Res. 2018;5(3):349-52.
Wang W, Xie X, Yuan T. Epidemiological trends of maternal hypertensive disorders of pregnancy at the global, regional, and national levels: a population‐based study. BMC Pregnancy Childbirth. 2021;21:364.
Mathew R, Devanesan BP, Srijana NS, Sreedevi. Prevalence of hypertensive disorders of pregnancy, associated factors and pregnancy complications in a primigravida population. Gynecol Obstetr Clin Med. 2023;3(2):119-23.